LFST insider updates holdings to 376,430 after RSU/PSU actions

Rhea-AI Filing Summary

LifeStance Health Group (LFST) reported a Form 4/A by its Chief People Officer correcting a prior filing. The amendment updates the number of shares withheld for taxes on PSUs vested on March 7, 2025 from 3,725 to 7,450, and updates holdings to 376,430 shares following the reported transactions.

Activity included: a grant of 76,142 RSUs on March 6, 2025; tax withholdings of 6,455 shares at $7.88 on March 6, 2025; PSU vestings of 27,740 and 32,052 on March 7, 2025; and additional tax withholdings of 7,450 shares at $7.59 and 8,606 shares at $7.59. The filing notes these withholdings reduce shares delivered and are not open‑market sales.

Insights

Equity compensation analyst

Routine Form 4/A correcting tax-withheld shares; neutral impact.

The amendment adjusts a clerical count for PSU tax withholdings from 3,725 to 7,450 shares tied to vesting on March 7, 2025. Such updates align reported deliveries with net-settlement mechanics and do not reflect market sales.

Reported equity movements include a 76,142 RSU grant on March 6, 2025 and PSU vestings of 27,740 and 32,052, with tax withholdings at $7.88 and $7.59. Post-transaction beneficial ownership is 376,430 shares. Actual trading activity is not indicated; the noted withholdings are administrative.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Varanakis Ann

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
03/10/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2025		A		76,142(1)	A	$0.00	339,149	D
Common Stock	03/06/2025		F(2)		6,455	D	$7.88	332,694	D
Common Stock	03/07/2025		A		27,740(3)	A	$0.00	360,434	D
Common Stock	03/07/2025		F(4)		7,450	D	$7.59	352,984	D
Common Stock	03/07/2025		A		32,052(5)	A	$0.00	385,036	D
Common Stock	03/07/2025		F(6)		8,606	D	$7.59	376,430	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 76,142 restricted stock units ("RSUs") granted on March 6, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 6, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

3. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 8, 2024, which vested on March 7, 2025.

4. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

5. Represents PSUs previously granted to the Reporting Person on February 28, 2024, which vested on March 7, 2025.

6. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 7, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.

Remarks:

The Form 4 previously filed on March 10, 2025 reported that 3,725 shares were withheld by the Issuer to satisfy withholding tax obligations in connection with the net settlement of PSUs that vested on March 7, 2025 as 3,725 in the fourth row of table 1 above. This Form 4 is being filed to amend the number of shares withheld to be 7,450 and to update the number of shares reported as securities beneficially owned following the reported transaction.

	By: /s/ Ryan Pardo, Attorney-in-Fact	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.